For example, acquired KRAS (G12C) or BRAF (G469A, V599E, or V600E) confer resistance to EGFR, MET, or ALK TKIs in NSCLC.117, 143, 158, 159, 160, 161. The gene discussed is BRAF; the disease is non-small cell lung carcinoma.